Cohort analyses reported in the present study confirm that Nrh-R expression may be a better prognostic marker regarding response to chemotherapy and further support the relevance of targeting the Nrh/IP3R1 complex for cancer treatment. The gene discussed is ITPR1; the disease is cancer.